Showing 1‐28 of 432
Unveiling Consumer Preferences for Oral Solid Dosage Forms. Capsules in the Spotlight
Capsules & Health Ingredients   |  White paper
Unveiling Consumer Preferences for Oral Solid Dosage Forms. Capsules in the Spotlight
The article "Unveiling Consumer Preferences for Oral Solid Dosage Forms. Capsules in the Spotlight" delves into the intricate rela...
/knowledge-center/chi/nutraceuticals/capsules/oral-solid-dosage-forms
7 min read
Straight to Market in an Autoinjector
Biologics   |  White paper
Straight to Market in an Autoinjector
A smart, data-driven approach to formulate biotherapeutics for PFS with confidence The global prefilled syringe (PFS) market was ...
/knowledge-center/biologics/es/straight-to-market-in-an-autoinjector
6 min read
GS Effex® Cell Line for Enhanced Antibody Effector Function
Biologics   |  Technical/Service brief
GS Effex® Cell Line for Enhanced Antibody Effector Function
GS Effex® derived from Lonza's leading GS Xceed® cell line, has been engineered to lack the enzyme responsible for the addition of...
/knowledge-center/biologics/brief/gs-effex-cell-line
5 min read
GS Xceed® Gene Expression System Brochure
Biologics   |  Technical/Service brief
GS Xceed® Gene Expression System Brochure
GS Xceed® is a scalable, integrated, proven platform for developing biotherapeutics. The system is supported by Lonza’s extensive ...
/knowledge-center/biologics/brief/gs-xceed-gene-expression-system
Early Solid Form Screening: A Case Study
Small Molecules   |  White paper
Early Solid Form Screening: A Case Study
Solid form screening is highly customizable based on the phase of the drug development life cycle, and collaborating with an exper...
/knowledge-center/smallmolecules/es/early-solid-form-screening
14 min read
Accelerating Small Molecule Advancements
Small Molecules   |  e-book
Accelerating Small Molecule Advancements
The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex an...
/knowledge-center/smallmolecules/e/accelerating-small-molecule-advancements
20 min read
Cis-targeted Immunotherapies Need Large CDMO Expertise but also Flexibility
Biologics   |  Article
Cis-targeted Immunotherapies Need Large CDMO Expertise but also Flexibility
Asher Biotherapeutics is developing a pipeline of cis-targeted immunotherapies that selectively activate only the immune cell type...
/knowledge-center/biologics/a/small-biotech-success-asher-flexibility
3 min read
Transparent Communication Supports Tech Transfers of Cis-targeted Immunotherapies
Biologics   |  Article
Transparent Communication Supports Tech Transfers of Cis-targeted Immunotherapies
Asher Biotherapeutics embarked on a search for a contract development and manufacturing organization (CDMO) that could handle Phas...
/knowledge-center/biologics/a/small-biotech-success-asher-communication
3 min read
Rapid and Material-Sparing Feasibility Screening for Hot Melt Extrusion
Small Molecules   |  Presentation (on-demand)
Rapid and Material-Sparing Feasibility Screening for Hot Melt Extrusion
Amorphous solid dispersions (ASD) offer a bioavailability enhancement drug delivery solution for otherwise poorly soluble crystall...
/knowledge-center/smallmolecules/pres/feasibility-screening-hot-melt-extrusion
Meeting the Challenge of Rising API Complexity
Small Molecules   |  Webinar (on-demand)
Meeting the Challenge of Rising API Complexity
The complexity of small molecule active pharmaceutical ingredients (APIs) is rising, bringing longer syntheses that challenge inno...
/knowledge-center/smallmolecules/w/route-scouting-rising-api-complexity
Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing
Small Molecules   |  Webinar (on-demand)
Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing
A recent study revealed, that the pharmaceutical industry is significantly more emission-intensive than the automotive industry1. ...
/knowledge-center/smallmolecules/w/process-redesign-sustainability-small-molecule-manufacturing
Increasing the Bioavailability of Oncology Drugs with Amorphous Solid Dosage Formulations
Small Molecules   |  White paper
Increasing the Bioavailability of Oncology Drugs with Amorphous Solid Dosage Formulations
Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the...
/knowledge-center/smallmolecules/es/increase-bioavailability-amorphous-solid-dispersions
16 min read
Establishing the Standards of Operational Excellence to Manufacture Commercial Cell Therapies
Cell & Gene   |  Webinar (on-demand)
Establishing the Standards of Operational Excellence to Manufacture Commercial Cell Therapies
After entering Phase 3, cell and gene therapies experience nearly five times more discontinuations or significant delays due to CM...
/knowledge-center/cellgene/w/cgt-operational-excellence
Identify Your Lead Solid Form Early to Reduce Timelines and Downstream Costs
Small Molecules   |  Article
Identify Your Lead Solid Form Early to Reduce Timelines and Downstream Costs
Devoting early-phase resources to finding the lead solid form of an active pharmaceutical ingredient (API) can save you time and r...
/knowledge-center/smallmolecules/a/identify-lead-solid-form
5 min read
Scale up Considerations for Dry Powder Inhaler Manufacturing by Spray Drying
Small Molecules   |  Webinar (on-demand)
Scale up Considerations for Dry Powder Inhaler Manufacturing by Spray Drying
Spray drying is a versatile particle-engineering tool used to produce respirable dry powders of small molecule APIs and biologics....
/knowledge-center/smallmolecules/w/dpi-scale-up-spray-drying
Developing Breakthrough Technology for Oral Solid Dosage Forms
Capsules & Health Ingredients   |  R&D Blog post
Developing Breakthrough Technology for Oral Solid Dosage Forms
Delivering treatment in the small intestine and not the stomach represents a unique drug delivery challenge relevant to microbiome...
/knowledge-center/Blogs/oral-solid-dosage-forms
4 min read
Inhalation Particle Engineering with Jet Milling
Small Molecules   |  Podcast
Inhalation Particle Engineering with Jet Milling
Jet milling is a well-established particle engineering technique for producing micronized powders with controlled particle size di...
/knowledge-center/smallmolecules/Podcasts/powder-to-particles
Key Elements to Drug Product Process Characterization for Liquid and Lyophilized DP to Support a BLA Submission
Biologics   |  Webinar (on-demand)
Key Elements to Drug Product Process Characterization for Liquid and Lyophilized DP to Support a BLA Submission
Access our on-demand webinar on preparing for a successful BLA submission. The pathway to market authorization of a new biotherap...
/knowledge-center/biologics/w/bla-submission-drug-product-process-characterization
Reducing Wastewater Incineration and Carbon Emission
Small Molecules   |  White paper
Reducing Wastewater Incineration and Carbon Emission
As the pharmaceutical industry works to develop more sustainable processes for large-scale drug manufacturing, companies are comin...
/knowledge-center/smallmolecules/es/reducing-wastewater-incineration
10 min read
bluebird bio and Lonza reflect on their 10-year journey commercializing two gene therapies
Cell & Gene   |  Video
bluebird bio and Lonza reflect on their 10-year journey commercializing two gene therapies
bluebird bio and Lonza take the opening plenary stage at the CAR-TCR Summit to tell the story of their 10-year journey bringing tw...
/knowledge-center/cellgene/v/car-tcr-summit-boston
Technology Transfers In Sterile Manufacturing
Biologics   |  White paper
Technology Transfers In Sterile Manufacturing
Overcoming the Challenges of Transferring Complex Biological Products The biopharmaceutical industry has seen many challenges in ...
/knowledge-center/biologics/es/technology-transfers-biological-products-sterile-manufacturing
20 min read
How to Accelerate Your Biotherapeutics' Path to Clinic
Biologics   |  Article
How to Accelerate Your Biotherapeutics' Path to Clinic
Over the last few decades, many novel biotherapeutics have undergone clinical trial testing in the quest to address unmet medical ...
/knowledge-center/biologics/a/accelerate-biotherapeutics-path-to-clinic
Addressing Challenges with Clinical In-Use Testing of Biotherapeutics
Biologics   |  Article
Addressing Challenges with Clinical In-Use Testing of Biotherapeutics
The goal of in-use testing of biotherapeutics is to ensure acceptable product quality during dose preparation and administration ...
/knowledge-center/biologics/a/challenges-clinical-testing-biotherapeutics
15 min read
Effective Technology Transfers For Mammalian-Derived Biologics
Biologics   |  White paper
Effective Technology Transfers For Mammalian-Derived Biologics
The complex set of activities involved in technical transfers of pharmaceutical innovations from research laboratories to clinical...
/knowledge-center/biologics/es/effective-technology-transfers-for-mammalian-derived-biologics
18 min read
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon® Platform
Cell & Gene   |  Peer-reviewed publication
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon® Platform
Abstract: Autologous cell-based therapeutics have gained increasing attention in recent years because of their efficacy at treatin...
/knowledge-center/cellgene/pub/automated-t-cells-manufacturing-cocoon
Transfer and Development of Mammalian Processes: Effective technology transfer for mammalian derived biopharmaceuticals ensuring process consistency and product quality
Biologics   |  Webinar (on-demand)
Transfer and Development of Mammalian Processes: Effective technology transfer for mammalian derived biopharmaceuticals ensuring process consistency and product...
Translating innovations from research laboratories to clinical and commercial manufacturing is a complex process that requires eff...
/knowledge-center/biologics/w/tech-tranfer-mammalian
Strategies to Optimize Expression Challenges of Multi-chain and Bispecific Antibodies
Biologics   |  Article
Strategies to Optimize Expression Challenges of Multi-chain and Bispecific Antibodies
Many of today's expression platforms for recombinant protein manufacturing have been optimised for the expression of monoclonal an...
/knowledge-center/biologics/a/expression-challenges-multi-bispecific-antibodies
20 min read
Tools for Developing Successful Biologics – XS Pichia® Expression System
Biologics   |  Article
Tools for Developing Successful Biologics – XS Pichia® Expression System
Lonza subject matter experts talk about the XS® Pichia Expression System and how it could benefit challenges with biotherapeutic e...
/knowledge-center/biologics/a/xs-pichia-expression-system
1 2 3 4 ... 16 >
Meet our experts

Our community is composed of technical experts who have decades of experience in a range of topics and project challenges.

View all experts
Meet our Biologics experts
Meet our Small Molecules experts